ArriVent BioPharma, Inc. (AVBP)

NASDAQ: AVBP · Real-Time Price · USD

24.81

+1.38 (5.89%)

At close: Mar 9, 2026, 4:00 PM EDT

24.81

0.00 (0.00%)

After-hours: Mar 9, 2026, 4:10 PM EDT

ArriVent BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	45.54	74.29	150.39	163.37
Short-Term Investments	267.28	144.57	-	-
Cash & Short-Term Investments	312.82	218.86	150.39	163.37
Cash Growth	42.93%	45.53%	-7.95%	-
Other Current Assets	20.08	8.12	9.58	19.25
Total Current Assets	332.9	226.98	159.97	182.62
Net Property, Plant & Equipment	0.01	0.15	0.29	0.14
Long-Term Investments	-	47.68	-	-
Other Long-Term Assets	0.26	0.13	2.84	0.07
Total Assets	333.17	274.94	163.1	182.83
Accounts Payable	5.93	3.78	4.53	3.09
Accrued Expenses	20	13.33	6.95	5.14
Current Portion of Leases	0.01	0.16	0.14	0.13
Total Current Liabilities	25.95	17.27	11.62	8.36
Long-Term Leases	-	0.01	0.18	0.01
Total Long-Term Liabilities	-	0.01	0.18	0.01
Total Liabilities	25.95	17.29	11.8	8.37
Common Stock	0	0	-	-
Additional Paid-in Capital	711.85	496.2	4.65	3.4
Accumulated Other Comprehensive Income	0.01	-0.21	-	-
Retained Earnings	-404.64	-238.33	-157.85	-88.51
Total Common Shareholders' Equity	307.22	257.65	-153.19	-85.11
Minority Interest	-	-	304.49	149.87
Shareholders' Equity	307.22	257.65	151.3	64.76
Total Liabilities & Equity	333.17	274.94	163.1	182.83
Total Debt	0.01	0.18	0.32	0.14
Net Cash (Debt)	312.81	218.69	150.07	163.23
Net Cash Growth	43.04%	45.72%	-8.06%	-
Net Cash Per Share	8.13	6.95	70.10	127.82
Book Value	307.22	257.65	-153.19	-85.11
Book Value Per Share	7.99	8.19	-71.55	-66.64
Tangible Book Value	307.22	257.65	-153.19	-85.11
Tangible Book Value Per Share	7.99	8.19	-71.55	-66.64

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q